Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $71.20 and last traded at $71.20, with a volume of 200 shares trading hands. The stock had previously closed at $52.54.
Wall Street Analyst Weigh In
Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a report on Thursday, August 1st.
Get Our Latest Analysis on PHMMF
Pharma Mar Stock Performance
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to Start Investing in Real Estate
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What is an Earnings Surprise?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
